| Followers | 149 |
| Posts | 2303 |
| Boards Moderated | 0 |
| Alias Born | 01/24/2012 |
Thursday, February 23, 2023 8:36:38 AM
$Assertio Holdings Inc This is a very smart move by the company, here is why and what it does. In short, buy the friking dip.
These transactions?? reduce our overall debt by $30M, or 42.9%, while consuming only $10.5M in cash (and issue ~$7M shares). In addition, the transactions will ??save the company $2M in annual interest payments, reduce the potential dilution from the exchanged convertible notes by 4.6%, and will be accretive to our diluted EPS by $0.02 in 2023," CEO Dan Peisert commented.
??????????????????????????????
These transactions?? reduce our overall debt by $30M, or 42.9%, while consuming only $10.5M in cash (and issue ~$7M shares). In addition, the transactions will ??save the company $2M in annual interest payments, reduce the potential dilution from the exchanged convertible notes by 4.6%, and will be accretive to our diluted EPS by $0.02 in 2023," CEO Dan Peisert commented.
??????????????????????????????
Recent ASRT News
- Form SC14D9C - Written communication relating to third party tender offer • Edgar (US Regulatory) • 04/29/2026 09:08:52 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/29/2026 09:07:22 PM
- Assertio and Garda Mutually Agree to Extend Tender Offer Deadline • Business Wire • 04/29/2026 08:30:00 PM
- Form SC14D9C - Written communication relating to third party tender offer • Edgar (US Regulatory) • 04/21/2026 09:15:47 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/21/2026 09:15:20 PM
- Assertio Provides Update on Garda Therapeutics Tender Process • Business Wire • 04/21/2026 09:00:00 PM
- Form SC14D9C - Written communication relating to third party tender offer • Edgar (US Regulatory) • 04/14/2026 09:09:45 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/14/2026 08:41:12 PM
- Form SC14D9C - Written communication relating to third party tender offer • Edgar (US Regulatory) • 04/09/2026 09:24:04 PM
- Form SC TO-C - Written communication relating to an issuer or third party • Edgar (US Regulatory) • 04/09/2026 09:16:11 PM
- Form 8-K/A - Current report: [Amend] • Edgar (US Regulatory) • 04/09/2026 09:15:20 PM
- Form SC14D9C - Written communication relating to third party tender offer • Edgar (US Regulatory) • 04/09/2026 12:11:45 PM
- Form SC TO-C - Written communication relating to an issuer or third party • Edgar (US Regulatory) • 04/09/2026 12:09:52 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/09/2026 12:07:14 PM
- Assertio Announces Agreement to be Acquired by Garda Therapeutics • Business Wire • 04/08/2026 08:04:00 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 04/06/2026 09:26:04 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 03/16/2026 09:07:06 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/16/2026 08:07:06 PM
- Assertio Reports Fourth Quarter and Full Year 2025 Financial Results • Business Wire • 03/16/2026 08:05:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/04/2026 12:26:39 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/04/2026 12:25:06 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/04/2026 12:23:51 AM
- Assertio Holdings, Inc. to Report Fourth Quarter and Full Year 2025 Financial Results on March 16, 2026 • Business Wire • 03/03/2026 09:30:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/24/2026 11:02:27 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/24/2026 11:01:53 PM
